Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as
determined by a 30 minute intraductal secretin stimulation test in patients with a low
likelihood of pancreatic pathology and to compare these data to those obtained from our
historical patients with suspected chronic pancreatitis. These will be patients in which
inadvertent pancreatic cannulation occurs during therapeutic endoscopic retrograde
cholangiopancreatography (ERCP) for biliary indications . All study subjects will receive a 5
day follow-up phone call. Enrollment goal is 36 subjects.